Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Blood pressure drug increases SARS-CoV-2 receptors in transmission and pathogenesis associated  tissues

Blood pressure drug increases SARS-CoV-2 receptors in transmission and pathogenesis associated tissues

Study suggests seropositive individuals produce anti-SARS-CoV-2 antibodies with improved potency and breadth

Study suggests seropositive individuals produce anti-SARS-CoV-2 antibodies with improved potency and breadth

SARS-CoV-2 Delta variant transmitted by fully vaccinated individuals in Provincetown, Massachusetts

SARS-CoV-2 Delta variant transmitted by fully vaccinated individuals in Provincetown, Massachusetts

How COVID-19 affects household food security

How COVID-19 affects household food security

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

COVID lockdowns affect preschoolers' eating, activity and sleep routines, parents say

COVID lockdowns affect preschoolers' eating, activity and sleep routines, parents say

Compared to influenza, COVID-19 is more likely to cause venous thrombosis

Compared to influenza, COVID-19 is more likely to cause venous thrombosis

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

A comparison between Pfizer/BioNTech's and Sinopharm's SARS-CoV-2 vaccines

A comparison between Pfizer/BioNTech's and Sinopharm's SARS-CoV-2 vaccines

Immune evasion by SARS-CoV-2 facilitated by a mutational hotspot in the NTD

Immune evasion by SARS-CoV-2 facilitated by a mutational hotspot in the NTD

Does previous SARS-CoV-2 infection affect vaccine-induced immunity?

Does previous SARS-CoV-2 infection affect vaccine-induced immunity?

Mapping the molecular gene signatures of respiratory viruses, including SARS-CoV-2

Mapping the molecular gene signatures of respiratory viruses, including SARS-CoV-2

Vaccination data from Puerto Rico strongly supports COVID19 booster shots

Vaccination data from Puerto Rico strongly supports COVID19 booster shots

Chemical substance may specifically inhibit both SARS-CoV-2 proteases and human protease

Chemical substance may specifically inhibit both SARS-CoV-2 proteases and human protease

Mu and C.1.2 variant spike proteins partially resistant to neutralization by vaccine-elicited antibodies

Mu and C.1.2 variant spike proteins partially resistant to neutralization by vaccine-elicited antibodies

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

Immunogenicity and efficacy of adjuvanted SARS-CoV-2 beta variant subunit booster in rhesus macaques

Immunogenicity and efficacy of adjuvanted SARS-CoV-2 beta variant subunit booster in rhesus macaques

Replication of SARS-CoV-2 variants in different cell and organ models

Replication of SARS-CoV-2 variants in different cell and organ models

Development of a safe and effective COVID-19 nanoparticle vaccine

Development of a safe and effective COVID-19 nanoparticle vaccine

Hydrogel-based vaccine delivery system evokes antibody response against SARS-CoV-2

Hydrogel-based vaccine delivery system evokes antibody response against SARS-CoV-2

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.